Related Experiment Video
Updated: Jun 23, 2026

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Smooth muscle progenitor cells: friend or foe in vascular disease?
Olivia van Oostrom1, Joost O Fledderus, Dominique de Kleijn
1Department of Vascular Medicine, University Medical Center Utrecht, The Netherlands.
Insights
The origin of vascular smooth muscle cells in neointima formation is debated. This review explores the role of bone marrow-derived smooth muscle progenitor cells in vascular disease, aiding therapeutic development.
Area of Science:
- Vascular Biology
- Cellular Heterogeneity
- Regenerative Medicine
Background:
- Vascular smooth muscle cell (VSMC) origin in neointima formation is debated in diseases like atherosclerosis.
- VSMCs are heterogeneous, exhibiting distinct phenotypes in health and disease.
- Bone marrow-derived progenitor cells (BMSPCs) are implicated in vascular repair.
Purpose of the Study:
- To review the heterogeneity of VSMCs.
- To discuss the role of BMSPCs in vascular disease and neointima formation.
- To explore therapeutic strategies targeting BMSPCs for vascular disease prevention.
Main Methods:
- Literature review of studies on VSMC heterogeneity.
- Analysis of research on BMSPCs in vascular disease models.
- Discussion of potential regulatory mechanisms and therapeutic implications.
Main Results:
- BMSPCs have been detected in human atherosclerotic tissue and mouse models.
- The contribution of BMSPCs to neointima formation ('friend' or 'foe') is unclear.
- Understanding BMSPC roles is crucial for developing novel therapies.
Conclusions:
- VSMC heterogeneity is a key factor in vascular disease.
- BMSPCs may play a significant role in neointima formation.
- Targeting BMSPCs offers potential for novel therapeutic interventions in vascular diseases.
Abstract:
The origin of vascular smooth muscle cells that accumulate in the neointima in vascular diseases such as transplant arteriosclerosis, atherosclerosis and restenosis remains subject to much debate. Smooth muscle cells are a highly heterogeneous cell population with different characteristics and markers, and distinct phenotypes in physiological and pathological conditions. Several studies have reported a role for bone marrow-derived progenitor cells in vascular maintenance and repair. Moreover, bone marrow-derived smooth muscle progenitor cells have been detected in human atherosclerotic tissue as well as in in vivo mouse models of vascular disease. However, it is not clear whether smooth muscle progenitor cells can be regarded as a 'friend' or 'foe' in neointima formation. In this review we will discuss the heterogeneity of smooth muscle cells, the role of smooth muscle progenitor cells in vascular disease, potential mechanisms that could regulate smooth muscle progenitor cell contribution and the implications this may have on designing novel therapeutic tools to prevent development and progression of vascular disease.
More Related Videos
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
08:43Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
Published on: February 14, 2017
Related Concept Videos
Mesenchymal Stem Cells
Structure of Blood Vessels
Vascular Spasm
Multipotency of Hematopoietic Stem Cells
Regulation of Angiogenesis and Blood Supply
Introduction to Fibroblasts